The Impact of Lipoprotein Apheresis on Inflammatory Factors: A Systematic Review and Meta‐Analysis
Journal of Clinical Apheresis · 2025
DOI: 10.1002/jca.70082 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Clinical Apheresis, 2025. Verfasst von Alireza Hatami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Blood Transfusion, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Hauptthemen laut MEDLINE: Blood Component Removal, Lipoproteins, Inflammation, Dyslipidemias. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Lipoprotein apheresis is a well‐established therapy for patients with dyslipidemia unresponsive to conventional lipid‐lowering strategies. However, its impact on systemic inflammation remains uncertain. This systematic review and meta‐analysis evaluated the effect of apheresis on circulating inflammatory markers, including C‐reactive protein (CRP), high‐sensitivity CRP (hs‐CRP), interleukin‐6 (IL‐6), and tumor necrosis factor‐alpha (TNF‐α). Following PRISMA guidelines, a systematic search of PubMed, Scopus, and ISI Web of Science was conducted up to June 2025. Studies reporting pre‐ and post‐apheresis values for inflammatory markers were included. Standardized mean differences (SMD) and 95% confidence intervals (CI) were calculated. Thirteen publications met inclusion criteria. Meta‐analysis demonstrated that apheresis significantly reduced CRP levels (SMD = −0.31; 95% CI: −0.44 to −0.18; p < 0.001), particularly in long‐term interventions. No significant changes were observed for IL‐6, TNF‐α, or hs‐CRP. In conclusion, apheresis significantly reduces CRP levels, especially with long‐term treatment, suggesting a modest anti‐inflammatory benefit. However, its effects on other markers remain unclear. Larger and high‐quality trials are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Blood Transfusion, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
- Department of Surgery, School of Clinical Sciences, Monash University, Melbourne, Australia.
- Clinical Research Development Center, Baharloo Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
- Institute of General Pathology and Pathophysiology, Moscow, Russia.
- Department of Molecular Biology and Genetics, Canakkale Onsekiz Mart University, Canakkale, Turkey.
- Department of Laboratory Sciences and Hematology, Faculty of Allied Medical Sciences, North Khorasan University of Medical Sciences, Bojnurd, Iran.
ORCID-Profile: Vasily N Sukhorukov, Amirhossein Sahebkar
Förderung
- Russian Science Foundation
Zitieren
APA
Hatami, A., Eslami, M., Aslani, S., Alizadeh, S., Sukhorukov, V. N., Karav, S., Razi, B., & Sahebkar, A. (2025). The Impact of Lipoprotein Apheresis on Inflammatory Factors: A Systematic Review and Meta‐Analysis. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70082
Vancouver
Hatami A, Eslami M, Aslani S, Alizadeh S, Sukhorukov VN, Karav S, et al. The Impact of Lipoprotein Apheresis on Inflammatory Factors: A Systematic Review and Meta‐Analysis. Journal of Clinical Apheresis. 2025. doi:10.1002/jca.70082
BibTeX
@article{Hatami2025,
author = {Hatami, Alireza and Eslami, Masoud and Aslani, Saeed and Alizadeh, Shahab and Sukhorukov, Vasily N and Karav, Sercan and Razi, Bahman and Sahebkar, Amirhossein},
title = {The Impact of Lipoprotein Apheresis on Inflammatory Factors: A Systematic Review and Meta‐Analysis},
journal = {Journal of Clinical Apheresis},
year = {2025},
doi = {10.1002/jca.70082}
}
EUVIMED